All cancer types
Results
Phase 1/2
This trial was looking at a drug called AUY922 for cancers that had continued to grow despite having other treatments.
Recruitment start: 23 July 2007
Recruitment end: 31 July 2011
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Udai Banerji
Experimental Cancer Medicine Centre (ECMC)
Novartis
Last reviewed: 12 Aug 2014
CRUK internal database number: 4064